Shiro Tanaka

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. doi request reprint Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Int J Clin Oncol 18:17-25. 2013
  2. doi request reprint Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women
    S Tanaka
    Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Osteoporos Int 24:69-76. 2013
  3. doi request reprint Statistical issues and recommendations for noninferiority trials in oncology: a systematic review
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto 606 8507, Japan
    Clin Cancer Res 18:1837-47. 2012
  4. ncbi request reprint Predicting long-term mortality after first coronary revascularization: – the Kyoto model –
    Shiro Tanaka
    Translational Research Center, Kyoto University Hospital, Japan
    Circ J 76:328-34. 2012
  5. pmc Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial
    Takayuki Nakagawa
    Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    BMC Med 8:76. 2010
  6. doi request reprint Size of Creutzfeldt-Jakob disease epidemic associated with cadaveric dura transplantation
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan
    Neuroepidemiology 34:232-7. 2010
  7. pmc Design paper: a phase II study of bevacizumab and erlotinib in patients with non-squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous treatment (BEST)
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyoku, Kyoto 606 8507, Japan
    Trials 12:120. 2011
  8. doi request reprint The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women--A joint analysis of the Nagano, Miyama, and Taiji Cohorts
    Shiro Tanaka
    Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University, Kyoto, Japan
    Bone 47:1064-70. 2010
  9. doi request reprint Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women
    Shiro Tanaka
    Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University, Sakyo ku, Kyoto, Japan
    J Bone Miner Res 26:2778-84. 2011
  10. pmc Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease
    Naoya Tanabe
    Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo ku, Kyoto, Japan
    Respir Res 13:31. 2012

Collaborators

Detail Information

Publications21

  1. doi request reprint Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Int J Clin Oncol 18:17-25. 2013
    ....
  2. doi request reprint Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women
    S Tanaka
    Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Osteoporos Int 24:69-76. 2013
    ..7 years showed that overweight/obesity and underweight are both risk factors for fractures at different sites. Fracture risk assessment may be improved if fracture sites are taken into account and BMI is categorized...
  3. doi request reprint Statistical issues and recommendations for noninferiority trials in oncology: a systematic review
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto 606 8507, Japan
    Clin Cancer Res 18:1837-47. 2012
    ..Two trials (3%) specified 2 values of margins. Our findings highlight critical deficiencies in design and reporting of noninferiority trials. Seven practical recommendations are presented...
  4. ncbi request reprint Predicting long-term mortality after first coronary revascularization: – the Kyoto model –
    Shiro Tanaka
    Translational Research Center, Kyoto University Hospital, Japan
    Circ J 76:328-34. 2012
    ..We explored the determinants of mortality in order to develop and validate the Kyoto model, which predicts outcomes after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG)...
  5. pmc Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial
    Takayuki Nakagawa
    Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    BMC Med 8:76. 2010
    ..We tested the safety and efficacy of topical insulin-like growth factor 1 (IGF1) application using gelatin hydrogels as a treatment for SSHL...
  6. doi request reprint Size of Creutzfeldt-Jakob disease epidemic associated with cadaveric dura transplantation
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan
    Neuroepidemiology 34:232-7. 2010
    ..Despite wide recognition that the epidemic is the consequence of shortcomings in the regulation of organ transplantation and the tardy decision-making by the Japanese health ministry, the size of the d-CJD epidemic remains unknown...
  7. pmc Design paper: a phase II study of bevacizumab and erlotinib in patients with non-squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous treatment (BEST)
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyoku, Kyoto 606 8507, Japan
    Trials 12:120. 2011
    ..We are conducting a single arm phase II trial which aims to evaluate the efficacy and safety of this regime as a second- or third-line chemotherapy...
  8. doi request reprint The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women--A joint analysis of the Nagano, Miyama, and Taiji Cohorts
    Shiro Tanaka
    Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University, Kyoto, Japan
    Bone 47:1064-70. 2010
    ....
  9. doi request reprint Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women
    Shiro Tanaka
    Division of Clinical Trial Design and Management, Translational Research Center, Kyoto University, Sakyo ku, Kyoto, Japan
    J Bone Miner Res 26:2778-84. 2011
    ..Urinary pentosidine improves risk classification using conventional risk assessment tools. Optimal clinical strategies of diagnosis and treatment remain uncertain and in need of additional investigation...
  10. pmc Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease
    Naoya Tanabe
    Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo ku, Kyoto, Japan
    Respir Res 13:31. 2012
    ..However, whether the rate of the decline in lung function is independently affected by the regional distribution or the severity of emphysema in the whole lung is unclear...
  11. doi request reprint Coronary revascularization in patients with liver cirrhosis
    Akira Marui
    Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, and Translational Research Center, Kyoto University Hospital, Kyoto, Japan
    Ann Thorac Surg 91:1393-9. 2011
    ..However, percutaneous coronary intervention (PCI) or off-pump coronary artery bypass graft surgery (OPCABG) may be a less invasive alternative strategy...
  12. doi request reprint Comparison of frequency of postoperative stroke in off-pump coronary artery bypass grafting versus on-pump coronary artery bypass grafting versus percutaneous coronary intervention
    Akira Marui
    Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Am J Cardiol 110:1773-8. 2012
    ..Occurrence of early stroke after OPCAB was lower than that after on-pump CABG, yet occurrences of delayed and late strokes were similar for the 3 revascularization strategies...
  13. pmc Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis
    Akira Marui
    Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, and Translational Research Center, Kyoto University Hospital, Kyoto, Japan
    Eur J Cardiothorac Surg 41:94-101. 2012
    ..The objective of the present study was to compare the outcomes after PCI, on-pump CABG (ONCAB), and OPCAB in patients with multivessel and/or left main disease...
  14. doi request reprint MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy
    Kazuna Takeda
    Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyoku, Kyoto 606 8507, Japan
    Eur J Radiol 81:2148-53. 2012
    ..To investigate if there is any difference in evaluation of residual tumor size after neoadjuvant chemotherapy (NAC) and neoadjuvant endocrine therapy (NAE)...
  15. doi request reprint Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan
    Hiroki Nagai
    Outpatient Oncology Unit, Kyoto University Hospital, Kyoto, 606 8507, Japan
    Int J Clin Oncol 16:560-7. 2011
    ..Therefore, we aimed to clarify the safety profile of erlotinib...
  16. doi request reprint Objective patterning of uroflowmetry curves in children with daytime and nighttime wetting
    Akihiro Kanematsu
    Department of Urology, Kyoto University, Kyoto, Japan
    J Urol 184:1674-9. 2010
    ..Pediatric uroflowmetry curve interpretation is incompletely standardized. Thus, we propose new, objective patterning...
  17. doi request reprint Fruit intake and incident diabetic retinopathy with type 2 diabetes
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Sakyo ku, Kyoto, Japan
    Epidemiology 24:204-11. 2013
    ..We investigated this association in a cohort with type 2 diabetes 40-70 years of age with hemoglobin (Hb)A1C ≥6.5%, originally part of the Japan Diabetes Complications Study...
  18. doi request reprint Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathy
    Masashi Kanai
    Outpatient Oncology Unit, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto 606 8507, Japan
    Cancer Epidemiol 34:189-93. 2010
    ....
  19. doi request reprint A multi-center study of pediatric uroflowmetry data using patterning software
    Akihiro Kanematsu
    Department of Urology, Kyoto University, Japan
    J Pediatr Urol 9:57-61. 2013
    ..We created software for patterning uroflowmetry (UFM) curves, and validated its utility...
  20. pmc Longitudinal study of spatially heterogeneous emphysema progression in current smokers with chronic obstructive pulmonary disease
    Naoya Tanabe
    Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    PLoS ONE 7:e44993. 2012
    ..However, a longitudinal CT study has not investigated whether continuous smoking causes the spatially heterogeneous progression of emphysema...
  21. doi request reprint Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study
    Mami Iima
    Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyoku, Kyoto 606 8507, Japan
    Radiology 260:364-72. 2011
    ..To evaluate the potential of apparent diffusion coefficients (ADCs) obtained at quantitative diffusion-weighted magnetic resonance (MR) imaging of the breast as a biomarker of low-grade ductal carcinoma in situ (DCIS)...